Edwards Lifesciences Corporation (ETR:EWL)
68.34
+0.46 (0.68%)
At close: Jan 30, 2026
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of €39.74 billion as of February 2, 2026. Its market cap has decreased by -1.36% in one year.
Market Cap
39.74B
Enterprise Value
37.09B
Revenue
5.01B
Ranking
n/a
PE Ratio
34.09
Stock Price
€68.34
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from 984.05M to 39.74B, an increase of 3,938.35%. That is a compound annual growth rate of 15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 39.74B | -5.68% |
| Dec 31, 2025 | 42.13B | -0.09% |
| Dec 31, 2024 | 42.17B | 0.80% |
| Dec 29, 2023 | 41.84B | -3.07% |
| Dec 30, 2022 | 43.16B | -39.31% |
| Dec 31, 2021 | 71.12B | 53.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Volkswagen AG | 51.53B |
| Deutsche Post AG | 50.60B |
| Siemens Healthineers AG | 47.05B |
| E.ON SE | 46.68B |
| Bayer Aktiengesellschaft | 43.78B |
| Heidelberg Materials AG | 40.80B |
| BASF SE | 40.49B |
| Deutsche Börse AG | 39.09B |